Kalehua Capital Management »

Moonlake Immunot shares owned by Kalehua Capital Management

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Kalehua Capital Management from 13F filings

Historical chart of Kalehua Capital Management investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Kalehua Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Kalehua Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.3M 176k 18.64

More positions owned by Kalehua Capital Management

Alpha Architect 1-3 Month Box ETF Alpha Arch 1-3 (BOXX)
X4 Pharmaceuticals Com New (XFOR)
Surrozen Com New (SRZN)
Veradermics Common Stock
Relay Therapeutics (RLAY)
Sionna Therapeutics (SION)
Aclaris Therapeutics (ACRS)
Inhibikase Therapeutics Com New (IKT)
Oruka Therapeutics (ORKA)
Pharvaris N V (PHVS)
Uniqure NV SHS (QURE)
Septerna (SEPN)
Compass Pathways Sponsored Ads (CMPS)
Athira Pharma (LONA)
Damora Therapeutics Com New (DMRA)

View all positions for Kalehua Capital Management

Top funds holding Moonlake Immunot

BVF
Deep Track Capital
Cormorant Asset Management
Henderson Group
D. E. Shaw & Co
Citadel Advisors
MPM Oncology Impact Management
Weiss Asset Management LP[1
Logos Global Management
Point72 Asset Management
Susquehanna International
Goldman Sachs Group
Two Sigma Investments
Balyasny Asset Management
BlackRock

View all funds holding Moonlake Immunot